BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 27932480)

  • 1.
    Bierzynska A; Soderquest K; Dean P; Colby E; Rollason R; Jones C; Inward CD; McCarthy HJ; Simpson MA; Lord GM; Williams M; Welsh GI; Koziell AB; Saleem MA; ;
    J Am Soc Nephrol; 2017 May; 28(5):1614-1621. PubMed ID: 27932480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of MAGI2-RapGEF2-Rap1 signaling contributes to podocyte dysfunction in congenital nephrotic syndrome caused by mutations in MAGI2.
    Zhu B; Cao A; Li J; Young J; Wong J; Ashraf S; Bierzynska A; Menon MC; Hou S; Sawyers C; Campbell KN; Saleem MA; He JC; Hildebrandt F; D'Agati VD; Peng W; Kaufman L
    Kidney Int; 2019 Sep; 96(3):642-655. PubMed ID: 31171376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered expression of Crb2 in podocytes expands a variation of CRB2 mutations in steroid-resistant nephrotic syndrome.
    Udagawa T; Jo T; Yanagihara T; Shimizu A; Mitsui J; Tsuji S; Morishita S; Onai R; Miura K; Kanda S; Kajiho Y; Tsurumi H; Oka A; Hattori M; Harita Y
    Pediatr Nephrol; 2017 May; 32(5):801-809. PubMed ID: 27942854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid Resistant Nephrotic Syndrome-Genetic Consideration.
    Tasic V; Gucev Z; Polenakovic M
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015; 36(3):5-12. PubMed ID: 27442391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis of steroid-resistant nephrotic syndrome.
    Antignac C
    Nefrologia; 2005; 25 Suppl 2():25-8. PubMed ID: 16050398
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Hermle T; Schneider R; Schapiro D; Braun DA; van der Ven AT; Warejko JK; Daga A; Widmeier E; Nakayama M; Jobst-Schwan T; Majmundar AJ; Ashraf S; Rao J; Finn LS; Tasic V; Hernandez JD; Bagga A; Jalalah SM; El Desoky S; Kari JA; Laricchia KM; Lek M; Rehm HL; MacArthur DG; Mane S; Lifton RP; Shril S; Hildebrandt F
    J Am Soc Nephrol; 2018 Aug; 29(8):2123-2138. PubMed ID: 29959197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease management.
    Bierzynska A; McCarthy HJ; Soderquest K; Sen ES; Colby E; Ding WY; Nabhan MM; Kerecuk L; Hegde S; Hughes D; Marks S; Feather S; Jones C; Webb NJ; Ognjanovic M; Christian M; Gilbert RD; Sinha MD; Lord GM; Simpson M; Koziell AB; Welsh GI; Saleem MA
    Kidney Int; 2017 Apr; 91(4):937-947. PubMed ID: 28117080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid Response to Cyclosporin A and Favorable Renal Outcome in Nongenetic Versus Genetic Steroid-Resistant Nephrotic Syndrome.
    Büscher AK; Beck BB; Melk A; Hoefele J; Kranz B; Bamborschke D; Baig S; Lange-Sperandio B; Jungraithmayr T; Weber LT; Kemper MJ; Tönshoff B; Hoyer PF; Konrad M; Weber S;
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):245-53. PubMed ID: 26668027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel NPHS2 variant in patients with familial steroid-resistant nephrotic syndrome with early onset, slow progression and dominant inheritance pattern.
    Suvanto M; Patrakka J; Jahnukainen T; Sjöström PM; Nuutinen M; Arikoski P; Kataja J; Kestilä M; Jalanko H
    Clin Exp Nephrol; 2017 Aug; 21(4):677-684. PubMed ID: 27573339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo expression of podocyte slit diaphragm-associated proteins in nephrotic patients with NPHS2 mutation.
    Zhang SY; Marlier A; Gribouval O; Gilbert T; Heidet L; Antignac C; Gubler MC
    Kidney Int; 2004 Sep; 66(3):945-54. PubMed ID: 15327385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of genetic causes for sporadic steroid-resistant nephrotic syndrome in adults.
    Gribouval O; Boyer O; Hummel A; Dantal J; Martinez F; Sberro-Soussan R; Etienne I; Chauveau D; Delahousse M; Lionet A; Allard J; Pouteil Noble C; Tête MJ; Heidet L; Antignac C; Servais A
    Kidney Int; 2018 Nov; 94(5):1013-1022. PubMed ID: 30348286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Systematic Analysis of Major Susceptible Genes in Childhood-onset Steroid-resistant Nephrotic Syndrome.
    Li Y; He Q; Wang Y; Dang X; Wu X; Li X; Shuai L; Yi Z
    Ann Clin Lab Sci; 2019 May; 49(3):330-337. PubMed ID: 31308032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural Basis of Highly Specific Interaction between Nephrin and MAGI1 in Slit Diaphragm Assembly and Signaling.
    Weng Z; Shang Y; Ji Z; Ye F; Lin L; Zhang R; Zhu J
    J Am Soc Nephrol; 2018 Sep; 29(9):2362-2371. PubMed ID: 30006415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase Separation of MAGI2-Mediated Complex Underlies Formation of Slit Diaphragm Complex in Glomerular Filtration Barrier.
    Zhang H; Lin L; Liu J; Pan L; Lin Z; Zhang M; Zhang J; Cao Y; Zhu J; Zhang R
    J Am Soc Nephrol; 2021 Aug; 32(8):1946-1960. PubMed ID: 34330769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel variants in CRB2 targeting the malfunction of slit diaphragm related to focal segmental glomerulosclerosis.
    Yang Q; Tang D; Gan C; Bai M; Song X; Jiang W; Li Q; Chen Y; Zhang A; Wang M
    Pediatr Nephrol; 2024 Jan; 39(1):149-165. PubMed ID: 37452832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NPHS2 mutations in sporadic steroid-resistant nephrotic syndrome in Japanese children.
    Maruyama K; Iijima K; Ikeda M; Kitamura A; Tsukaguchi H; Yoshiya K; Hoshii S; Wada N; Uemura O; Satomura K; Honda M; Yoshikawa N
    Pediatr Nephrol; 2003 May; 18(5):412-6. PubMed ID: 12687458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defects of CRB2 cause steroid-resistant nephrotic syndrome.
    Ebarasi L; Ashraf S; Bierzynska A; Gee HY; McCarthy HJ; Lovric S; Sadowski CE; Pabst W; Vega-Warner V; Fang H; Koziell A; Simpson MA; Dursun I; Serdaroglu E; Levy S; Saleem MA; Hildebrandt F; Majumdar A
    Am J Hum Genet; 2015 Jan; 96(1):153-61. PubMed ID: 25557779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic testing in steroid-resistant nephrotic syndrome: when and how?
    Lovric S; Ashraf S; Tan W; Hildebrandt F
    Nephrol Dial Transplant; 2016 Nov; 31(11):1802-1813. PubMed ID: 26507970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome.
    Ruf RG; Lichtenberger A; Karle SM; Haas JP; Anacleto FE; Schultheiss M; Zalewski I; Imm A; Ruf EM; Mucha B; Bagga A; Neuhaus T; Fuchshuber A; Bakkaloglu A; Hildebrandt F;
    J Am Soc Nephrol; 2004 Mar; 15(3):722-32. PubMed ID: 14978175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence.
    Weber S; Gribouval O; Esquivel EL; Morinière V; Tête MJ; Legendre C; Niaudet P; Antignac C
    Kidney Int; 2004 Aug; 66(2):571-9. PubMed ID: 15253708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.